Cystoid Macular Edema Following Cultured Human Corneal Endothelial Cell Injection: Incidence, Risk Factors, and Visual Prognosis

Cystoid Macular Edema Following Cultured Human Corneal Endothelial Cell Injection: Incidence, Risk Factors, and Visual Prognosis

This review synthesizes current evidence on the frequency and risk factors of cystoid macular edema (CME) after cultured human corneal endothelial cell (cHCEC) injection, highlighting prostaglandin analog use as a key associated factor and discussing the visual outcomes and management strategies.
Unveiling the TL1A-LTα1β2/IL-22 Axis: A New Therapeutic Target in Crohn’s Disease with Perianal Fistulising Disease

Unveiling the TL1A-LTα1β2/IL-22 Axis: A New Therapeutic Target in Crohn’s Disease with Perianal Fistulising Disease

This study reveals that TL1A-activated CD4+ T cells drive distinct cellular and molecular changes in the rectal mucosa of Crohn's disease patients with perianal fistulising disease (PFD), highlighting a novel TL1A-LTα1β2/IL-22 axis independent of TNF signaling, with important therapeutic implications.
New 2026 EASD Guideline: Practical, Evidence-Based Care for Diabetes Distress in Adults with Type 1 and Type 2 Diabetes

New 2026 EASD Guideline: Practical, Evidence-Based Care for Diabetes Distress in Adults with Type 1 and Type 2 Diabetes

The 2026 EASD guideline provides practical, evidence-based recommendations for routine assessment and management of diabetes distress in adults with type 1 or type 2 diabetes, including validated screening, eight Good Practice Statements, and conditional GRADE recommendations for psychological and technology-based interventions.